Skip to main content
ConductScienceScienceDex

Herman O Sintim

NIH Rank #10815
Unclaimed recordClaim profile
  • R01 Holder
  • Translational
  • Multi-Institutional
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 9042278Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pathology
  • CHEMISTRY
  • Pharmacology

NIH Funding · FY2025

Linked Award Amount
$1.4M
Full award amounts, FY2025
Award Records
3
Records listing this PI
Award-Linked Rank
#10,815
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Herman O Sintim. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Herman O Sintim as a PI. Multi-PI records show the full award amount for context.

  • 5R01CA273168-04R01
    Discovery of the next-generation RET-targeted drugs based on nicotinamide scaffold
    University of Oklahoma Health Sciences Center
    $580.7K
    award amount
  • 7R01CA267978-04R01
    3H-pyrazolo[4,3-f]quinoline-containing compounds as selective and tunable protein kinase inhibitors
    University of Notre Dame
    $462K
    award amount
  • 5R01CA177585-10R01
    Targeting MYC promoter G-quadruplex for MYC inhibition by Indenoisoquinolines
    Purdue University
    $387.2K
    award amount

Award organizations

Organizations that administered FY2025 awards listing Herman O Sintim as a PI.

University of Oklahoma Health Sciences Center
OK
$580.7K
1 grant
University of Notre Dame
IN
$462K
1 grant
Purdue University
IN
$387.2K
1 grant

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of Oklahoma Health Sciences Center
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #5785
  5. 2025
    $2M Cumulative Funding
  6. 2025
    Multi-Institutional Research
    Awards at 3 institutions
  7. 2025
    R01 Grant Holder

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Herman O Sintim.

Funda Meric-bernstam
University of Oklahoma Health Sciences Center
3
shared awards
Jie Wu
University of Oklahoma Health Sciences Center
3
shared awards
Danzhou Yang
Purdue University
2
shared awards
Reuben Kapur
University of Notre Dame
2
shared awards
Reuben Kapur
Purdue University
1
shared award
X. Frank Yang
Indiana University Indianapolis
1
shared award

Explore further

Find collaborators for Herman O Sintim

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →